Samsung Biologics Co Ltd - ESG Rating & Company Profile powered by AI
The ESG rating for Samsung Biologics Co Ltd represents the company's transparency towards the United Nations SDGs. If you are employed by Samsung Biologics Co Ltd and you would like to licence your ESG aseessment, please contact us. The assessment of Samsung Biologics Co Ltd is assembled by All Street Sevva using cutting edge artificial intelligence.
Samsung Biologics Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 3.0 and governance score of 3.4.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | Samsung Biologics Co Ltd | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Samsung Biologics Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Samsung Biologics Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Samsung Biologics Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Samsung Biologics Co Ltd offer flexible work?
Sign up for free to unlockDoes Samsung Biologics Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Samsung Biologics Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Samsung Biologics Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose water use targets?
Sign up for free to unlockDoes Samsung Biologics Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Samsung Biologics Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Samsung Biologics Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Samsung Biologics Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Samsung Biologics Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Samsung Biologics Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Samsung Biologics Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Samsung Biologics Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Samsung Biologics Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Samsung Biologics Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Samsung Biologics Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.